Evidence map›Paper›PMID 32564170›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

A metastatic tumor is no different to a viral pandemic: lessons learnt from COVID-19 may teach us to change the PRRT paradigm.

Giovanni Paganelli, Lisa Bodei, Irvin Modlin

Open access · bronzeAbstract readEditorialHistorical Article
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Giovanni PaganelliNuclear Medicine Operative Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014, Meldola, Italy.
Lisa BodeiDepartment Nuclear Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Irvin ModlinSchool of Medicine, Yale University, New Haven, CT, 06520, USA. imodlin@optonline.net.
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori · ITMemorial Sloan Kettering Cancer Center · USYale University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronavirus InfectionsCOVID-19Disease ProgressionHealth Services ResearchHistory, 21st CenturyHumansMedical OncologyNeoplasm MetastasisNeuroendocrine TumorsOctreotideOrganometallic CompoundsPandemicsPneumonia, ViralPublic HealthRisk AssessmentSevere Acute Respiratory Syndromelutetium Lu 177 dotatateOctreotideOrganometallic CompoundsSomatostatinCOVIDFDG-PETNETestNeuroendocrine tumorPPQPRRT

Identifiers

PMID32564170
PMCPMC7305056
OpenAlexW3036458244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.